Interim Results - Part 1

Microgen PLC 5 September 2000 PART 1 1/2 5 SEPTEMBER 2000 MICROGEN plc ('Microgen') Interim Results for the Six months ended 30 June 2000 HIGHLIGHTS - Results in line with Board's expectations and consistent with the Group's disciplined investment program in e-services. 'Sell-side' B2B e-business model developing well. - Revenue from continuing operations of £11.0m (1999 : £8.7m). - EBITDA for continuing operations £0.5m (1999 : £0.2m) and adjusted PBT from continuing operations (excl exceptional items, goodwill amortisation and charges related to share price) of £0.5m (1999: £0.1m). - Adjusted earnings per share of 0.2p, including discontinued operations which contributed an operating loss of £0.5m on turnover of £2.8m (1999 : eps of 2.5p including an operating profit of £1.7m on turnover of £6.8m from discontinued operations). - Billing & Database Management : After completion of the substantial restructuring over the past two years, the division is now focused on database management and billing services using an ASP model. Over 70 corporate customers have now signed up to Microgen's ASP e-services for a total of over 100 applications, including over 30 adopting business-to-business ('B2B') e-billing. The disciplined investment program in e-services has enabled operating income (£0.3 million before Group overheads) to be maintained whilst undergoing a major transformation of the operations. Major recent customer wins for e-services include : 3-Com, Canon, Cisco Systems, Lafarge Redland Aggregates, NHS Logistics Authority, Oyezstraker Office Supplies, Wolseley and Staples. - Microgen-Kaisha : The Group's consultancy division, focused on the delivery of e-business, CRM and data warehousing, had a good start to the year with revenue of £3.8m and operating profit before Group overhead and goodwill amortisation of £0.9m, an operating margin of 24%. Major recent customer wins have included : 3i, First Group, UDV, Jigsaw (a consortium comprising Unilever, Kimberley Clark and Cadbury) and BskyB. Additional projects have been secured from existing clients including : Centrica, LloydsTSB Registrars, Thames Water and Vodafone. - Recent acquisition of Telesmart Developments Ltd ('Telesmart') enables Microgen to provide a market-leading integrated e-billing and e-payment service solution for the B2B sector, establishing Microgen at the forefront of 'sell-side' B2B e-business services. - Exit from the declining COM business, disposal of Ireland operations and closure of Manchester print bureau completed on schedule and on target (exceptional costs of £2 million). Martyn Ratcliffe, Executive Chairman, commented : ' The Board are pleased with the organic and strategic progress, transforming the Group into a leading position in 'sell-side' e-business services. While most B2B e-business activity in the market to date has focused on 'buy-side' e-procurement, the Board believes that the potential of the 'sell-side' opportunity is far greater, since virtually all companies seek to enhance their customer relationships. Consistent with this sell-side strategy, the Group's consultancy division has very effectively repositioned its core CRM skills into the e-business sector and is increasingly delivering the synergies anticipated at the time of the Kaisha acquisition.' Contacts Martyn Ratcliffe, Executive Chairman 01753-847123 Mike Phillips, Group Finance Director Steve Liebmann, Buchanan Communications 020-7466-5000 Interim Results and 'Sell-Side' e-Business presentation will be available from www.microgen.co.uk from 2-00pm today 5 SEPTEMBER 2000 MICROGEN plc ('Microgen') Interim Results for the Six months ended 30 June 2000 CHAIRMAN'S STATEMENT During the first half of 2000, the Group has made substantial progress, successfully completing the two year transition program and further developing growth opportunities, both organic and strategic. The Microgen Group now comprises two operating divisions, both of which delivered a positive operating contribution, despite the investments being made in the e-services business where the Board continues to pursue a self-funded, disciplined investment program to maximise the potential of the e-business opportunities developed by the Group. The success of these activities has positioned Microgen at the forefront of 'sell-side' e-services in the UK. Financial Performance In the six months ended 30 June 2000, Microgen generated EBITDA from continuing operations of £0.5 million (1999 : £0.2 million) from revenue of £11.0 million (1999 : £8.7 million). Adjusted PBT for the continuing operations (excluding exceptional items, goodwill amortisation and charges related to share price movements) for the period ended 30 June 2000 was £0.5 million, compared with £0.1 million in 1999. Adjusted earnings per share were 0.2p, including discontinued operations which contributed an operating loss of £0.5m on turnover of £2.8m (1999 : eps of 2.5p including an operating profit of £1.7m on turnover of £6.8m from discontinued operations). The Group produced a net loss after tax of £2.5 million equivalent to a loss per share of 4.9p, after exceptional costs of £2 million related primarily to the transition program. (The exceptional costs for the year are still anticipated not to exceed £2.4 million.) Also included in the net loss were £0.2 million of costs associated with an aborted acquisition, an operating loss of £0.5 million from discontinued operations and goodwill amortisation of £0.6 million. The 1999 profit after tax of £1.0 million (earnings per share of included £0.2 million of goodwill amortisation costs but also a profit contribution of £1.7 million from the discontinued operations. The Group maintained a positive operating cash flow, consistent with the self-funding of the e-services investment program, and continues to have a robust balance sheet with net free cash of £10.0 million at 30 June 2000, reducing to £7.4 million following the acquisition of Telesmart Developments Ltd. As notified in the annual report for 1999, consistent with the investment program, the Board has decided that dividends will be paid once per year in respect of the full year results. Accordingly no interim dividend has been declared. Billing & Database Management The core technology for Microgen's e-services is the application service provision ('ASP') infrastructure, developed to enable the management of high volume transactional databases. Microgen now has over 70 customers signed up to over 100 ASP application services, all of which are based on the management and distribution of data. These applications are being adopted across many industry sectors and are being deployed to satisfy a variety of database management applications, including business-to-business ('B2B') e-billing, where Microgen now has over 30 companies adopting its B2B e-billing model. The ongoing investment in developing Microgen's sell-side e-services supplier (Biller) to enhance its relationship with its customers ( enables the Recipient). Developments include : - The acquisition of Telesmart Developments Ltd ('Telesmart') enabling an integrated B2B payment solution to be provided with the e-billing service. (Telesmart is one of the UK's leading suppliers of payment solutions using the BACS system whichis the primary medium for B2B payment transactions in the UK and the Telesmart customer base provides compatible marketing opportunities for the Microgen e-billing services. Post-acquisition integration is progressing well.) - Expansion of bill output formats, including 'Sage-ready' and XML, where Microgen has now received the Business and Accounting Software Developers Association (BASDA) eBIS-XML accreditation. - Biller-branded web pages to provide a seamless link to/from the Biller's web site, enabling the Biller to strengthen its brand,increase traffic to its web site and enhance its customerrelationships. - Capability for bill Recipient aggregation from multiple Billers - Capability for purchase order and/or forms integration As billers transition from traditional printing of invoices to e-bill distribution, Microgen's ability to manage the transition and deliver a complete service across multiple media is a key differentiator. As this transition evolves and demand for print media declines, the Board believe that the print industry will experience excess capacity and service commoditisation, resulting in pressure on margins. As a result, and as highlighted earlier in the year, a pro-active strategy has been adopted to reduce the Group's exposure to this risk while maintaining the relevant customers and the ability to manage this strategic transition for those customers. This decision resulted in the closure of the Manchester facility and consolidation of print bureau operations, which has been completed on schedule. Furthermore, some of the early benefits of the investment in the Central Processing Facility are already being realised with the establishment of outsource partners for excess print volumes and to provide disaster recovery capability, enabling Microgen to maximise the opportunity while reducing the risk exposure associated with the transition. Revenue from continuing operations in the division as a whole was £7.2 million (1999 : £7.5 million) producing operating profit before Group overhead of £0.3 million (1999 : £0.3 million). The decline in revenue occurred in the print & mail services through the bureau consolidation and continued account rationalisation while the on-line e-services grew by over 80% compared with the first half of 1999. This continued success confirms the effectiveness of the Board's disciplined investment program, balancing profitability and growth through this period of transition. The results for discontinued operations in note 1 highlight the reason for the Board's decision to accelerate the final phase of the transition program. The exit from COM, which was successfully completed in June including the disposal of the Ireland operations, marks a major milestone in the history of Microgen, being the service on which the company was first established. Microgen -Kaisha Microgen Kaisha : The Group's consultancy division, focused on the delivery of e-business, CRM and data warehousing, had a good start to the year with solid growth in the strategic sectors. Revenue for the division was £3.8m producing an operating profit before Group overhead and goodwill amortisation of £0.9m, equivalent to an operating margin of almost 24%. Revenue from legacy support services reduced to c.17% of the division for the six months ended 30 June 2000, compared with 34% in the comparable period last year. Utilisation rates have significantly improved and average fee rates have increased by 18% over the first half of 1999. This success has been achieved through a positioning of the business at the forefront of the technology curve, utilising the core CRM and data warehousing skills to maximise e-business developments for Microgen's customers. This positioning is consistent with the evolution of the Microgen Database Management business and the Group recently won a significant project to implement and then host and support a data warehouse and associated CRM applications for a major customer. This type of project, whereby the initial consultancy and project implementation can be enhanced by on-line database hosting and related services, confirms the synergies between the two operating divisions anticipated at the time of the Kaisha acquisition. As demand for Microgen-Kaisha e-CRM services continues to increase, the business has developed a set of proven tools branded 'Equinox', to accelerate deployment of e-CRM and Business Intelligence solutions. The Equinox tools enable the rapid integration of legacy applications and data sources with the latest CRM and e-business front-end applications, allowing customers to realise the inherent value of the data held in their existing systems by applying it through new customer-focused applications. Combined with the Microgen-Kaisha software vendor independence and the proven track record of successful systems deployment, the Equinox tools have been well received by clients, enabling accelerated delivery schedules and improved return on investment. Board of Directors Len Crisp retired from the Board in May 2000 following the successful integration of Kaisha into the Microgen Group. The Board would like to thank Len for his contribution during this period. Paul Davies joined the Board as Group Managing Director in 1999 and has made a substantial contribution to the successful execution of the Group's strategy during the past year. After a successful career Paul has now decided to retire from executive management but will remain on the Board of Microgen plc as non-executive Deputy Chairman. In this active role, Paul's experience and contribution to the strategic development of the Group will continue to be available to the executive team. Following these changes the Board will comprise a majority of non-executive directors, consistent with the Board's policy on corporate governance. Prospects Throughout the first half of the year, with its post-millennium and stock market unpredictability, the Board has maintained a disciplined, prudent approach which has continued to deliver planned operating performance whilst managing a major transition and investment program. This approach will be maintained. The demand experienced in the Consultancy division during the first half of the year is a result of positioning the business to provide leading technology services, a strategy that has proven very successful. Furthermore, the Board believe that the customer adoption rates for Microgen's e-business ASP services are at the higher end of the market sector and consider that the Group is well-positioned to benefit from increasing market acceptance of e-services. The acquisition of Telesmart provides an integrated e-billing and e-payment solution which should enhance the Microgen offering and the Board will continue to explore additional strategic opportunities which could potentially accelerate the development of the Group. In summary, the organic and strategic development of Microgen has produced an exciting opportunity at the forefront of 'sell-side' e-business in the UK and the Board continues to be pleased with the progress and evolution of the Group. Martyn Ratcliffe Executive Chairman MICROGEN PLC Group Profit and Loss Account for the Six Months ended 30 June 2000 Unaudited Unaudited Restated Notes 6 months 6 months year ended ended ended 30 June 30 June 31 Dec 2000 1999 1999 £'000 £'000 £'000 Turnover 1 - continuing operations 10,994 8,713 19,608 - discontinued operations 2,766 6,759 11,716 ------- ------- ------- 13,760 15,472 31,324 Operating costs (14,877) (14,509) (29,776) Operating (loss)/profit 1 Continuing operations (629) (740) (898) Discontinued operations (488) 1,703 2,446 Operating (loss)/profit 1 (1,117) 963 1,548 Loss on disposal of discontinued operations (140) - - Loss on disposal of fixed assets - discontinued operations (1,024) - - Restructuring costs - (773) - - discontinued operations Goodwill previously written off relating to the disposal of discontinued operations (100) - - ------- ----- ----- (Loss)/profit on ordinary activities before Interest and Tax (3,154) 963 1,548 Net interest 346 553 862 ------- ------ ------ (Loss)/profit on ordinary (2,808) 1,516 2,410 activities before tax Tax on (loss)/profit 2 351 (555) (620) on ordinary activities ------- ------ ------ (Loss)/profit on ordinary activities after taxation (2,457) 961 1,790 Dividends - (254) (762) ------- ------ ------ Retained (loss)/profit (2,457) 707 1,028 transferred to reserves ======= ====== ====== Earnings per share (after exceptional items, goodwill amortisation and charges related to share price movements) 3 Basic (4.9)p 2.1p 3.7p Diluted (4.7)p 2.1p 3.6p Adjusted earnings per share (before exceptional items, goodwill amortisation and charges related to share price movements) 3 Basic 0.2p 2.5p 5.8p Diluted 0.2p 2.5p 5.7p Dividend per share Nil 0.5p 1.5p MICROGEN PLC Consolidated Balance Sheet Unaudited Unaudited Restated as at as at as at 30 June 30 June 31 Dec 2000 1999 1999 Notes £'000 £'000 £'000 Fixed Assets - Tangible 2,224 5,251 4,524 - Intangible 23,650 24,853 24,276 - Investments 312 432 372 ------- ------- ------- 26,186 30,536 29,172 Current assets - Stocks - raw materials 171 130 288 - Debtors 4 5,090 7,182 4,855 - Cash at bank and in hand 18,091 22,252 18,824 ------- ------- ------- 23,352 29,564 23,967 Creditors: due within one 5 (13,966) (20,699) (13,494) year Net current assets 9,386 8,865 10,473 Total assets less current 35,572 39,401 39,645 liabilities Creditors: due after more 6 (105) (1,630) (1,265) than one year Provisions for liabilities (1,796) (2,285) (2,438) and charges ------- ------- ------- Net assets 33,671 35,486 35,942 ======= ======= ======= Equity capital and reserves - Called up share capital 7 2,544 2,539 2,543 - Share premium account 8 16,785 16,650 16,762 - Other reserves 8 200 100 150 - Profit and loss account 8 14,142 16,197 16,487 ------- ------- ------- Equity Shareholders' funds 33,671 35,486 35,942 MICROGEN PLC Consolidated Cash Flow Summary for the Six Months Ended 30 June 2000 Unaudited Unaudited Restated 6 months 6 months Year ended ended ended 31 Dec 30 June 30 June 1999 2000 1999 Notes £'000 £'000 £'000 Net cash flow from 9(i) 49 2,866 4,647 operating activities Returns on investments and 305 553 839 servicing of finance Taxation 89 (792) (5,522) Capital expenditure (71) (678) (1,001) and financial investment Acquisitions and disposals (324) (5,614) (5,658) Equity dividends paid to (509) (435) (688) shareholders ----- ------- ------- Cash (outflow) before use of (461) (4,100) (7,383) liquid resources and financing Management of liquid resources (766) 3,902 9,148 Financing (272) (343) (488) ------ ------- ------- (Decrease)/increase in cash 9(ii) (1,499) (541) 1,277 MORE TO FOLLOW
UK 100

Latest directors dealings